Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/07/2010 | US7846685 Methods and compositions for the control of coccidiosis |
12/07/2010 | US7846681 Apoptosis modulator BCL-B and methods for making and using same |
12/07/2010 | US7846679 Methods for detecting the presence of mutant mammalian presenilin protein |
12/07/2010 | US7846673 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas |
12/07/2010 | US7846671 Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence |
12/07/2010 | US7846670 Family of minimally cross-hybridizing nucleotide sequences for use in screening libraries for preferential gene sequences |
12/07/2010 | US7846669 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
12/07/2010 | US7846668 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
12/07/2010 | US7846667 Using myeloblastosis oncogene expression profile as tool in detection of cell proliferative disorders associated with respiratory system |
12/07/2010 | US7846665 Nucleic acid marker ladder for estimating mass |
12/07/2010 | US7846663 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
12/07/2010 | US7846660 Microarrays having multiple oligonucleotides in single array features |
12/07/2010 | US7846657 Nucleic acid probes for detection of preferential single nucleotide polymorphisms; diagnosing breast cancer |
12/07/2010 | US7846454 nucleotide sequences which encode infectious hepatitis C viruses, for development of vaccines and diagnostics for HCV and in the development of screening assays for the identification of antiviral agents for HCV |
12/07/2010 | US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
12/07/2010 | US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection |
12/07/2010 | US7846443 Antibodies to IL-17A |
12/07/2010 | US7846441 Treatment with anti-ErbB2 antibodies |
12/07/2010 | US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same |
12/07/2010 | US7846429 Compositions and methods for elimination of unwanted cells |
12/07/2010 | US7846428 Treating osteoarthritis via gene therapeutic plasmid comprising bone morphogenic protein sequences |
12/07/2010 | CA2525498C Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
12/07/2010 | CA2448211C Nucleic acid detection method |
12/07/2010 | CA2417570C Tumor-specific t cell activation by peptide antigens |
12/07/2010 | CA2398335C Herpes virus strains |
12/07/2010 | CA2355576C Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
12/07/2010 | CA2323576C Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
12/07/2010 | CA2301301C Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
12/07/2010 | CA2287505C Inhibitors of cellulolytic, xylanolytic and .beta.-glucanolytic enzymes |
12/07/2010 | CA2262406C Gene therapy for congestive heart failure |
12/07/2010 | CA2153653C Growth differentiation factor-9 |
12/02/2010 | WO2010138973A2 Advanced pathogen detection and screening |
12/02/2010 | WO2010138971A1 Plant gene regulatory elements |
12/02/2010 | WO2010138885A2 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses |
12/02/2010 | WO2010138806A2 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
12/02/2010 | WO2010138796A2 Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis |
12/02/2010 | WO2010138750A2 Generation of genetically corrected disease-free induced pluripotent stem cells |
12/02/2010 | WO2010138675A1 Simian adenovirus 41 and uses thereof |
12/02/2010 | WO2010138637A2 Fibromodulin peptide |
12/02/2010 | WO2010138631A1 Compositions and methods for production of aglycosylated plasminogen |
12/02/2010 | WO2010138555A2 Small peptide expression system in mammalian cells |
12/02/2010 | WO2010138263A2 Novel aav 's and uses thereof |
12/02/2010 | WO2010138084A1 CRYSTAL STRUCTURE OF CAP-FREE HUMAN eIF4E |
12/02/2010 | WO2010138011A1 A dna cassette, binary vector, and strain of a. tumefaciens and a method of producing cereal plant of increased productivity and/or root mass |
12/02/2010 | WO2010137900A2 Selective infracted-tissue-targeting bacteria and use thereof |
12/02/2010 | WO2010137873A2 Primer for the diagnosis of the new influenza a virus, probe, kit comprising same, and diagnosis method using the kit |
12/02/2010 | WO2010137744A1 New marker for detection of induced pluripotent stem cell |
12/02/2010 | WO2010137722A1 Method for screening of regenerative medicine |
12/02/2010 | WO2010137717A1 Method for highly sensitive detection of protein-protein interaction |
12/02/2010 | WO2010137671A1 Method for assessing lymph node metastasis of cancer or the risk thereof, and rapid assessment kit for said method |
12/02/2010 | WO2010137654A1 Pharmaceutical composition containing antagonist of egf family ligand as component |
12/02/2010 | WO2010137570A1 Anti-viral agent or an anti-cancer agent |
12/02/2010 | WO2010137547A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells |
12/02/2010 | WO2010137489A1 Glucose dehydrogenase having altered properties |
12/02/2010 | WO2010137295A1 Cdc45l peptides and vaccines including the same |
12/02/2010 | WO2010137130A1 Manufacturing method for an organic acid |
12/02/2010 | WO2010137020A1 Methods of treating inflammation |
12/02/2010 | WO2010137019A1 Photocatalytic hydrogen production in cyanobacteria |
12/02/2010 | WO2010136897A2 Expression of recombinant proteins |
12/02/2010 | WO2010136877A1 Muteins of the pyrroline-5-carboxylate reductase 1 |
12/02/2010 | WO2010136846A1 Differentiation therapy for sarcomas |
12/02/2010 | WO2010136841A2 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof |
12/02/2010 | WO2010136598A1 A collection and methods for its use |
12/02/2010 | WO2010136580A2 Tumour-specific bacterial promoter elements |
12/02/2010 | WO2010136577A1 Stim2-mediated capacitive calcium entry |
12/02/2010 | WO2010136549A2 Modified aav capsid polypeptides |
12/02/2010 | WO2010136536A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes |
12/02/2010 | WO2010136503A1 Method and device for producing and/or purifying polynucleotides and products obtainable thereof |
12/02/2010 | WO2010136417A1 miR-31 IN DUCHENNE MUSCULAR DYSTROPHY THERAPY |
12/02/2010 | WO2010136372A1 Process for reactivating silica surfaces for the isolation of nucleic acids |
12/02/2010 | WO2010135836A1 Novel beta-glucosidase enzymes |
12/02/2010 | WO2010135813A1 Increased seed oil and abiotic stress tolerance mediated by hsi2 |
12/02/2010 | WO2010135786A1 A method for diagnosing neoplasms and molecules for use therein |
12/02/2010 | WO2010115207A9 Chimeras between gpc-receptors and binding partners thereof |
12/02/2010 | WO2010111254A9 NOVEL ANTI-α5β1 ANTIBODIES AND USES THEREOF |
12/02/2010 | WO2010107957A3 RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
12/02/2010 | WO2010105194A3 Mesophilic and thermophilic organisms modified to produce acrylat, and methods of use thereof |
12/02/2010 | WO2010100278A3 Nucleic acids for cloning and expressing multiprotein complexes |
12/02/2010 | WO2010096678A3 Vesicular stomatitis virus vectors encoding hiv env epitopes |
12/02/2010 | WO2010091080A3 Nucleic acid purification |
12/02/2010 | WO2010088230A3 Adult stem cell assays |
12/02/2010 | WO2010083046A3 Methods for using next generation sequencing to identify 5-methyl cytosines in the genome |
12/02/2010 | WO2010065792A3 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
12/02/2010 | WO2010064204A3 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof |
12/02/2010 | WO2010062756A3 Preventing and treating sepsis |
12/02/2010 | WO2010056107A3 Method for identification of a molecular marker linked to the shell gene of oil palm |
12/02/2010 | WO2010046493A3 Gene transfer vectors comprising at least one isolated dna molecule having insulator and or boundary properties and methods to identify the same |
12/02/2010 | WO2009109597A8 Method for producing alpha- santalene |
12/02/2010 | WO2009067243A8 Modulation of cd40 expression |
12/02/2010 | US20100306881 improved ability to enzymatically degrade lignocellulosic feedstock; fermentation |
12/02/2010 | US20100306880 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them |
12/02/2010 | US20100306878 Highly efficient suppressor-dependent protein expression in plants with a viral vector |
12/02/2010 | US20100306877 Flavonoid glucosyltransferase and use of same |
12/02/2010 | US20100306876 Meg1 endosperm-specific promoters and genes |
12/02/2010 | US20100306875 Resistance gene and uses thereof |
12/02/2010 | US20100306874 Yield enhancement in plants by modulation of zmpkt |
12/02/2010 | US20100306873 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
12/02/2010 | US20100306871 Plants and seeds of hybrid corn variety ch293284 |
12/02/2010 | US20100306870 Tomato Hybrid 'Vespolino' |
12/02/2010 | US20100306869 Modulating production traits in avians |